Aurobindo Pharma Ltd announced that its Rs 800 crore buyback offer will open on April 23 and close on April 29. The company’s board approved the buyback of up to 54,23,728 fully paid-up equity shares at a price of Rs 1,475 per share on April 6. The record date for determining eligible equity shareholders is set for April 17.
The buyback represents 3.93 percent and 2.62 percent of the total paid-up equity share capital and free reserves, respectively, according to the audited financial statements as of March 31, 2025. Aurobindo Pharma stated that the buyback aims to reward shareholders and enhance overall returns, while also improving earnings per share and key financial ratios over time. The company confirmed that the buyback will not change control or affect its existing management structure.
